Castration-Resistant Prostate Carcinoma
Showing 1 - 25 of 55
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Stage IVB Prostate Cancer AJCC v8
- Biopsy
- +7 more
-
Scottsdale, Arizona
- +2 more
Feb 15, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Avelumab
- +4 more
-
Los Angeles, California
- +22 more
Feb 2, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate/Niraparib
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 9, 2023
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Berzosertib
- +3 more
-
Duarte, California
- +22 more
Jan 3, 2023
Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in
Recruiting
- Advanced Pancreatic Carcinoma
- +27 more
- Biopsy
- Talazoparib
-
Gainesville, Florida
- +3 more
Jan 3, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Dec 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United
Recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Laboratory Biomarker Analysis
- +3 more
-
La Jolla, California
- +21 more
Dec 2, 2022
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +5 more
- Questionnaire Administration
- Tin Sn 117m Pentetate
-
Lexington, KentuckyUniversity of Kentucky/Markey Cancer Center
Nov 26, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston
Completed
- Castration-Resistant Prostate Carcinoma
- +5 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Nov 9, 2022
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
- Acute Myeloid Leukemia
- +33 more
- Biospecimen Collection
- Medical Chart Review
-
Kingman, Arizona
- +99 more
Nov 3, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Laboratory Biomarker Analysis
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 19, 2022
Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen
Recruiting
- Castration-Resistant Prostate Carcinoma
- +7 more
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Enzalutamide
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 26, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
-
San Francisco, California
- +1 more
Sep 20, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
-
Detroit, Michigan
- +1 more
Aug 30, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)
Recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 23, 2022